Radiation Pneumonitis clinical trials
The registry lists 39 studies for Radiation Pneumonitis across more than 10 countries. 16 are recruiting or about to start. 16 of them are mainly about Radiation Pneumonitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Radiation Pneumonitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Huazhong University of Science and Technology (2) · Zhejiang Cancer Hospital (2) · Xinqiao Hospital of Chongqing (2) · The Second Affiliated Hospital of Chongqing Medical University (2) · Instituto Nacional de Cancerologia de Mexico (2) · Taipei Medical University WanFang Hospital (2) · University of Aarhus (2) · Second Hospital of Shanxi Medical University (1)
What is being tested here
Drugs under test in Radiation Pneumonitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Cisplatin | 1 | 1 | 1 |
| Nivolumab | 1 | 1 | 1 |
| Acetylcysteine | 1 | 0 | 1 |
| Dexamethasone | 1 | 0 | 1 |
| Budesonide | 1 | 0 | 1 |
| Babao dan | 1 | 0 | 1 |
| Fucoidan | 1 | 0 | 1 |
| Nintedanib | 0 | 0 | 2 |
| FAPI-46 | 0 | 0 | 1 |
| Adebrelimab | 0 | 0 | 1 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Dec 2026Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients · Instituto Nacional de Cancerologia de Mexico
- Dec 2026Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study · The Second Affiliated Hospital of Chongqing Medical University
- Dec 2026Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis · Guangdong Provincial People's Hospital
Who these studies take
Of the 12 Radiation Pneumonitis studies recruiting now, 6 (50%) set no upper age limit and 3 (25%) stop at 75 or younger. 1 (8%) take children under 18. 1 (8%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 11 (92%) | 10 (83%) |
| 30 | 12 (100%) | 11 (92%) |
| 40 | 12 (100%) | 11 (92%) |
| 50 | 12 (100%) | 11 (92%) |
| 65 | 12 (100%) | 11 (92%) |
| 75 | 10 (83%) | 9 (75%) |
| 85 | 8 (67%) | 7 (58%) |
Across all 39 studies, recruiting or not: 15% stop at 75 or younger and 0% at 65; 5% take children; 5% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 39 of 39. search them.
- Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With RadiotherapyRecruitingNCT065573431 country
- An App to Identify Radiation Pneumonitis - a Pre-Study in Healthy VolunteersNot yet recruitingNCT07824544Not applicable1 country
- Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung DiseaseRecruitingNCT05986318Phase 21 country
- Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer PatientsNot yet recruitingNCT077428001 country
- Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer PatientsRecruitingNCT03803787Phase 21 country
- Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung CancerRecruitingNCT04676828Not applicable2 countries
- Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical StudyRecruitingNCT07339644Not applicable1 country
- Correlation Between COVID-19 and Radiation Pneumonitis in Breast CancerNot yet recruitingNCT071881161 country
- Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor PneumonitisRecruitingNCT05455034Phase 1/21 country
- Hyperbaric Oxygen in the Prevention of Radiation PneumonitisRecruitingNCT05189496Not applicable1 country
- Radiotherapy Exposed Lung Injury: Effect on Functioning - CohortRecruitingNCT060691151 country
- Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLCRecruitingNCT065703171 country
- The Efficacy of Babaodan Capsules in Preventing Radiation PneumoniaRecruitingNCT06079931Phase 21 country
- Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyNot yet recruitingNCT06031597Phase 3
- Oligo-Fucoidan Decrease Lung Radiation DamageRecruitingNCT05616507Not applicable1 country
- A Study on Predictive Models and Clinical Outcome of Radiation PneumonitisRecruitingNCT054487031 country
- FAPI PET for Lung FibrosisActive, not recruitingNCT05365802Early Phase 11 country
- Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer RadiotherapyActive, not recruitingNCT073126821 country
- Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation PneumonitisCompletedNCT027357461 country
- Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation PneumonitisCompletedNCT02496585Phase 21 country
- The Formulation of Compound Phellinus Igniarius Decoction on Radiation PneumonitisCompletedNCT06861179Phase 11 country
- Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation PneumonitisActive, not recruitingNCT06700421Phase 21 country
- Clinical Study of Endostatin in Improving Radiation Pneumonia and FibrosisCompletedNCT03796364Phase 21 country
- IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation TherapyCompletedNCT036434841 country
- Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning.CompletedNCT048630271 country
- Study on the Biological Prediction Models of Radiation PneumonitisStatus unknownNCT024903191 country
- A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLCStatus unknownNCT04636593Phase 21 country
- Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer PatientsStatus unknownNCT04632342Phase 21 country
- Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapyTerminatedNCT02452463Phase 21 country
- Mitigation of Radiation Pneumonitis and FibrosisCompletedNCT01754909Phase 21 country
- Role of SPECT in Radiotherapy of Lung Cancer and Toxicity EvaluationCompletedNCT01745484Not applicable1 country
- Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone PropionateStatus unknownNCT03886441Phase 21 country
- Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary PhysiologyCompletedNCT034625241 country
- Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With ChemoradiationCompletedNCT015805791 country
- Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung CancerCompletedNCT00349102Phase 31 country
- Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer PatientsStatus unknownNCT02809456Phase 2
- Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung InjuryStatus unknownNCT02296281Phase 2
- Phase II Evaluation of Exhaled Nitric Oxide (NO)CompletedNCT013921441 country
- Risk Factors of Radiation PneumonitisStatus unknownNCT001559091 country